Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.43% | 166.86 | 0.7% | $1081.06m | |
| PFE | Pfizer Inc. | -1.38% | 48.59 | 0.9% | $912.26m | |
| LLY | Eli Lilly & Co. | 0.04% | 316.96 | 1.1% | $820.24m | |
| MRK | Merck & Co., Inc. | 0.42% | 91.42 | 0.7% | $782.30m | |
| ABBV | AbbVie, Inc. | -0.04% | 141.39 | 1.9% | $776.62m | |
| BMY | Bristol-Myers Squibb Co. | -0.55% | 74.15 | 1.0% | $614.48m | |
| SIGA | SIGA Technologies, Inc. | -6.42% | 23.18 | 0.0% | $439.36m | |
| AZN | AstraZeneca Plc | 0.12% | 66.50 | 1.0% | $365.07m | |
| GBT | Global Blood Therapeutics, Inc. | 0.08% | 67.05 | 5.6% | $352.06m | |
| GSK | GSK Plc | -0.17% | 34.25 | 0.3% | $285.96m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.14% | 223.45 | 8.2% | $270.68m | |
| HZNP | Horizon Therapeutics Plc | -0.84% | 61.21 | 5.4% | $225.68m | |
| CCXI | ChemoCentryx, Inc. | 0.43% | 51.00 | 2.9% | $213.70m | |
| KRTX | Karuna Therapeutics, Inc. | -0.08% | 261.01 | 0.0% | $204.69m | |
| VERU | Veru, Inc. | -21.47% | 18.68 | 0.0% | $196.18m |
Company Profile
Cybin, Inc. is an ethical biopharmaceutical company engaged in the development of therapeutics for patients to address a multitude of mental health issues. It is focused on progressing psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment regimens for mental health disorders. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.